| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2020 | Dec 17, 2020 | 4D Molecular Therapeutics, Inc. | Director | Buy | 100.0 | +100,000 | 100.00% | ✗ | $2.3M |
| Feb 15, 2018 | Feb 23, 2018 | GILEAD SCIENCES, INC. | CEO | Sell | 90.0 | +48,382 | 4.15% | ✗ | $646.2K |
| Nov 13, 2017 | Nov 15, 2017 | GILEAD SCIENCES, INC. | CEO | Sell | 12.5 | -220,000 | -15.87% | ✓ | $16M |
| Feb 15, 2017 | Feb 21, 2017 | GILEAD SCIENCES, INC. | CEO | Sell | 75.0 | +6,961 | 0.66% | ✗ | $589.8K |